OGT and hepatocellular carcinoma: For example, decreased O-GlcNAcylation caused by OGT inhibitor OSMI-1 enhances doxorubicin-induced apoptosis in hepatocellular carcinoma (HCC) cells (Lee and Kwon, 2020).